Mirion Technologies

Mirion Technologies, Inc. engages in the provision of nuclear measurement and detection systems. It offers measurement and enterprise, calibration, customer training programs, installation, product support and repairs, consulting, and instadose desimetry services. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Mirion Technologies posts robust Q4 earnings, eyes SMR market growth

Mirion Technologies reported strong financials, with double-digit revenue growth and a focus on reducing leverage, despite challenges like supply chain issues.
The company's strategic focus on the Medical and Industrial segments, along with opportunities in the SMR market, bode well for future growth.
Balanced growth strategies, disciplined capital allocation, and engagement in key markets position Mirion Technologies for continued success in 2023.

Mirion Technologies reports robust Q1 earnings, eyes growth opportunities

Mirion Technologies delivered strong Q1 results, focusing on operational efficiency, margin improvement, and cash flow generation. The company's rebranding efforts and positive market outlook position it well for future growth. With a history of margin expansion and free cash flow conversion, Mirion is poised for continued success in 2023.

Mirion Technologies posts robust Q2 results and eyes growth opportunities

Mirion Technologies delivered strong Q2 results with positive revenue growth and operational performance.
The company's focus on margin improvement and order intake positions it well for future success.
Despite challenges in pricing dynamics and cash flow, Mirion Technologies remains optimistic about its outlook.

Mirion Technologies excels in Q3 with strong order growth and record backlog

Mirion Technologies delivered a strong Q3 performance with significant order growth and record backlog, supported by strategic acquisitions and operational focus.
While facing challenges in organic growth and margin maintenance, the company remains optimistic about future opportunities for revenue expansion and profitability.
Maintaining financial targets, optimizing cash flow, and emphasizing margin expansion are key priorities for sustained success and market leadership.

Mirion Technologies reports record 2023 results and bullish 2024 guidance

Mirion Technologies had a stellar 2023, setting records in revenue, EBITDA, and free cash flow, with strong guidance for 2024.
The company is strategically focused on margin expansion, cost control, and product innovation to drive future growth.
While facing challenges in healthcare reimbursement and cost management, Mirion is leveraging international markets and new product introductions.
Confidence in achieving growth targets, Mirion remains committed to operational excellence and enhancing shareholder value.

Mirion Technologies reports solid Q1 performance, eyes growth opportunities

Mirion Technologies demonstrated strong financial performance in Q1 2024, driven by key growth drivers in nuclear power and cancer care. Despite challenges in cash flow and margin pressure, the company remains focused on growth opportunities through innovation and strategic initiatives.

Mirion Technologies reports solid Q2 results, eyes growth opportunities

Mirion Technologies showcased solid performance with margin exceeding expectations and raised EBITDA guidance. While facing tough order growth comps, the company is focused on driving organic growth and improving cost structure. Anticipated improvements in Chinese market dynamics and potential positive impact from upcoming CMS changes present growth opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. It operates through the Medical and Technologies segments. The Medical segment consists of sales, products, and services to customers in the medical market. The Technologies segment involves nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. The company was founded by Thomas D. Logan in December 2005 and is headquartered in Atlanta, GA.

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the second quarter of 2022 on Friday, July 29, 2022. Following the news release, the Company will host a conference call the same day at 10:00 am ET to discuss the results. Participants may access the call by calling 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be av

Mirion Technologies Announces Earnings Release and Conference Call Date for Second Quarter 2022

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), today announced the rebranding of its Medical segment as the Mirion Medical group, comprised of the organization's healthcare-focused Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units. The establishment of the Mirion Medical group reinforces the Mirion commitment to leveraging its expertise in ionizing radiation for healthcare applications. “Our keystone focus on ionizing radiation has broad app

Mirion Technologies Announces Mirion Medical Brand

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at CJS Securities' 22nd Annual “New Ideas” Summer Conference in Greenwich, CT on Tuesday, July 12, 2022. About Mirion Mirion Technologies is a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets. The organization aims to harness its

Mirion Technologies to Present at CJS Securities' 22nd Annual “New Ideas” Summer Conference

Also featured: SunCHECK™ Platform Updates, Newly Assimilated CIRS Solutions & Clinical User Insights MELBOURNE, Fla. , May 5, 2022 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), will feature its comprehensive solutions portfolio for independent, integrated Quality Management of Radiation Therapy and Diagnostic Imaging at the ESTRO 2022 Congress, held May 6-10 in Copenhagen, Denmark.

Sun Nuclear Highlights New SunSCAN™ 3D System & Smart Quality Management Solutions at ESTRO 2022

Mirion Technologies, Inc. (NYSE:MIR ) Q1 2022 Earnings Conference Call May 4, 2022 11:00 AM ET Company Participants Alex Gaddy - Vice President, Finance and Investor Relations Larry Kingsley - Chairman Tom Logan - Founding Chief Executive Officer Brian Schopfer - Chief Financial Officer Conference Call Participants Chris Moore - CJS Securities Andy Kaplowitz - Citigroup Joe Ritchie - Goldman Sachs Ronny Scardino - Goldman Sachs Operator Good day and welcome to the Mirion Technologies First Quarter 2022 Earnings Conference Call. [Operator Instructions] Please also note this event is being recorded.

Mirion Technologies, Inc. (MIR) CEO Tom Logan on Q1 2022 Results - Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for its fiscal quarter ended March 31, 2022. “Our teams responded well to the myriad of operating challenges that our company faced in the first quarter of 2022. Difficult comparisons on the industrial side of our business comp

Mirion Technologies Announces First Quarter 2022 Financial Results and Updates Full Year Guidance

System to Debut at ESTRO Annual Congress & Upcoming Online Release Event MELBOURNE, Fla. , May 3, 2022 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), today announced the release of the SunSCAN™ 3D cylindrical water scanning system for linear accelerator (linac) commissioning, beam scanning and annual Quality Assurance (QA) in Radiation Therapy.

Sun Nuclear Introduces SunSCAN™ 3D,Next-Generation Cylindrical Water Scanning System

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Goldman Sachs' Industrials and Materials Conference in New York, NY. The presentation will begin at 11:20 AM ET on Tuesday, May 10, 2022. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcas

Mirion Technologies to Present at Goldman Sachs' Industrials and Materials Conference

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Well Fargo's 2022 Industrials Conference in New York, NY. The presentation will begin at 12:00 PM ET on Thursday, May 5, 2022. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of the webcast will be a

Mirion Technologies to Present at Wells Fargo's 2022 Industrials Conference

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the first quarter of 2022 on Wednesday, May 4, 2022. Following the news release, the Company will host a conference call the same day at 11:00 am ET to discuss the results. Participants may access the call by calling 1-844-826-3033 or 1-412-317-5185, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be av

Mirion Technologies Announces Earnings Release and Conference Call Date for First Quarter 2022

ATLANTA--(BUSINESS WIRE)--Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), today announced the release of an enhanced Cloud-hosted, SaaS option for its SunCHECK™ Quality Management Platform. Through a centralized database and single interface, the SunCHECK Platform streamlines and standardizes workflows for Radiation Therapy Quality Assurance (QA) – to reduce risk and improve Patient Safety in cancer care. The SaaS model offer

Sun Nuclear Introduces New SaaS Option for its SunCHECK™ Quality Management Platform

Mirion Technologies, Inc. (MIR) CEO Tom Logan on Q4 2021 Results - Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion,” "we" or the "company") (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for its fiscal quarter and fiscal year ended December 31, 2021. “I am very proud of the results that our team was able to deliver for the fourth quarter and calendar year 2021. The last calendar quarter was quite eventful for M

Mirion Technologies Announces Results for the Fiscal Quarter and Fiscal Year Ended December 31, 2021

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi's 2022 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Thursday, February 24, 2022. The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section. An archive of t

Mirion Technologies to Present at Citi's 2022 Global Industrial Tech and Mobility Conference

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021 on Wednesday, February 23, 2022. Following the news release, the Company will host a conference call the same day at 10:00 am ET to discuss the results. Participants may access the call by calling 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnin

Mirion Technologies Announces Earnings Release and Conference Call Date for the Fourth Quarter and Fiscal Year Ended December 31, 2021

MELBOURNE, Fla., Jan. 14, 2022 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), today announced the full program for the 2022 QA & Dosimetry Symposium (QADS), April 8-9, in Orlando, Florida.

Sun Nuclear Announces 2022 QA & Dosimetry Symposium (QADS) Program

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the release of the Hyperion™ Compact Digital High Radiation Tolerant Camera, now offered in color and monochrome versions. With the Hyperion Compact camera's digital performance and radiation tolerance, cost of ownership can be reduced while performance is

Mirion Technologies Launches the Hyperion™ Compact Digital Radiation Tolerant Camera

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it had completed the acquisition of Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry. CIRS specializes in the design, development and commercializa

Mirion Technologies, Inc. Completes Acquisition of Computerized Imaging Reference Systems, Inc.

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the quarter ended September 30, 2021 for Mirion Technologies (TopCo), Ltd (“Legacy Mirion”). Legacy Mirion was the parent company for the Mirion business before the business combination with GS Acquisition Holdings Corp II (“GSAH”) which closed on October

Mirion Technologies Announces Results for the Fiscal Quarter Ended September 30, 2021

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE:MIR)(“Mirion”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the signing of a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry. CIRS specializes in the design, development and commercialization o

Mirion Technologies, Inc. to Acquire Computerized Imaging Reference Systems, Inc.; Expanding Capabilities in Existing Medical Platform

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR), announced today that it will release financial results for Mirion Technologies (TopCo), Ltd for the fiscal quarter ended September 30, 2021, on Friday, November 12, 2021 before the market opens. The company will host a conference call the same day at 8:00 am ET to present the results. Participants may access the call at 1-877-407-9208, international callers may use 1-201-493-6784, and request to join the Mirion Technologies earnin

Mirion Technologies Announces Date for Quarterly Earnings Release Conference Call

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion”), a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the acquisition of CHP Dosimetry, a U.S.-based distributor of dosimetry services. The acquisition closed on November 1, 2021. Headquartered in Clinton, TN, CHP Dosimetry provides dosimetry services for medical practices, veterinary offices, universities, and government agencies,

Mirion Technologies, Inc. Acquires Dosimetry Services Distributor Based in Clinton, Tennessee

ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets, announced that its Class A common stock and warrants will begin trading on the New York Stock Exchange today under the symbols “MIR” and “MIRW,” respectively. Management will participate in a closing bell ceremony at the New York Stock Exchange today, October 21, 2021, in celebration

News for Mirion Technologies Stock (MIR)